This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

A Conversation With Philip E. Pfrang


As the National Healthcare & Life Sciences Industry Leader of Deloitte’s M&A Transaction Services, Philip E. Pfrang has advised clients on more than 400 completed and proposed transactions and has extensive experience in cross-border and multinational deals. Directorship spoke with Pfrang about trends in the healthcare and life-sciences marketplace and his prognostications for M&A in the near term.

Read this conversation to gain more insights about Pfrang’s advice to directors on M&A trends.

Related links

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options

Stay connected